Pharmaceutical compositions comprising lobeglitazone for oral administration
Номер патента: CO2017004382A2
Опубликовано: 19-07-2017
Автор(ы): Dae Young Jung, Jong Lae Lim, Min Jae Joo, Shin Jung Park, Taek Hwan Shin
Принадлежит: Chong Kun Dang Pharmaceutical Corp
Опубликовано: 19-07-2017
Автор(ы): Dae Young Jung, Jong Lae Lim, Min Jae Joo, Shin Jung Park, Taek Hwan Shin
Принадлежит: Chong Kun Dang Pharmaceutical Corp
Реферат: La presente invención se refiere a composiciones farmacéuticas para administración oral que comprenden lobeglitazona. Las composiciones farmacéuticas de la presente invención tienen excelente velocidad de disolucion y expresan rápidos efectos farmacológicos al comprender derivados de celulosa. The present invention relates to pharmaceutical compositions for oral administration comprising lobeglitazone. The pharmaceutical compositions of the present invention have excellent dissolution rate and express rapid pharmacological effects by comprising cellulose derivatives.
Pharmaceutical composition comprising a cap-dependent endonuclease inhibitor
Номер патента: WO2024002054A1. Автор: Wei-Tsung Chen,Chung-Shu Hong. Владелец: Taigen Biopharmaceuticals Co. (Beijing) , Ltd.. Дата публикации: 2024-01-04.